Advancements and Applications of Artificial Intelligence in Hypertrophic Cardiomyopathy: A Comprehensive Review
Reviews in Cardiovascular Medicine · 12.03.2026 · 27 (3)
DOI: 10.31083/rcm44449 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Reviews in Cardiovascular Medicine, online erschienen am 12.03.2026. Verfasst von Huanhuan Ma und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Xijing Hypertrophic Cardiomyopathy Center, Xijing Hospital, Fourth Military Medical University, 710032 Xi'an, Shaanxi, Chin…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Major Project of China, National Natural Science Foundation of China, XinFei Talent Support Project of The Fourth Military Medical University.
Abstract (Originalsprache)
Hypertrophic cardiomyopathy (HCM) is a common cardiovascular disease and one of the leading causes of exercise-induced sudden cardiac death in adolescents. HCM presents complex diagnostic, prognostic, and management challenges due to the phenotypic heterogeneity and clinical course. Artificial intelligence (AI), machine learning (ML), and deep learning (DL) technologies are expected to transform the roles of echocardiography, electrocardiography (ECG), and cardiac magnetic resonance (CMR) imaging in the clinical management of HCM. AI methods can fully integrate clinical and imaging data to enable a comprehensive assessment of the risk profile of a patient. However, challenges remain, such as insufficient data standardization across multiple sources, limited model interpretability, and data privacy issues. Despite these challenges, AI-based approaches have the potential to revolutionize the management of HCM by providing timely, accurate diagnoses and personalized treatment strategies based on individual patient risk profiles. This review systematically examines the current landscape of AI applications in HCM data analytics, with a focus on methodological advancements and clinical implementations. Furthermore, this review aims to facilitate the transition from experience-based to data-driven paradigms in HCM diagnosis, thereby advancing precision medicine and individualized patient management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ultrasound, Xijing Hypertrophic Cardiomyopathy Center, Xijing Hospital, Fourth Military Medical University, 710032 Xi'an, Shaanxi, China.
- Office of Graduate Student Affairs, Xi'an Medical University, 710021 Xi'an, Shaanxi, China.
- Department of Information, Xijing Hospital, Fourth Military Medical University, 710032 Xi'an, Shaanxi, China.
ORCID-Profile: Huanhuan Ma, Fangqi Ruan, Liwen Liu
Förderung
- National Science and Technology Major Project of China
- National Natural Science Foundation of China
- XinFei Talent Support Project of The Fourth Military Medical University
- Xijing Hospital Medical Personnel Training Propel Project
Zitieren
APA
Ma, H., Li, J., Ta, S., Yu, L., Ruan, F., & Liu, L. (2026). Advancements and Applications of Artificial Intelligence in Hypertrophic Cardiomyopathy: A Comprehensive Review. Reviews in Cardiovascular Medicine, 27(3). https://doi.org/10.31083/rcm44449
Vancouver
Ma H, Li J, Ta S, Yu L, Ruan F, Liu L. Advancements and Applications of Artificial Intelligence in Hypertrophic Cardiomyopathy: A Comprehensive Review. Reviews in Cardiovascular Medicine. 2026;27(3). doi:10.31083/rcm44449
BibTeX
@article{Ma2026,
author = {Ma, Huanhuan and Li, Jing and Ta, Shengjun and Yu, Liang and Ruan, Fangqi and Liu, Liwen},
title = {Advancements and Applications of Artificial Intelligence in Hypertrophic Cardiomyopathy: A Comprehensive Review},
journal = {Reviews in Cardiovascular Medicine},
year = {2026},
volume = {27},
number = {3},
doi = {10.31083/rcm44449}
}
EUVIMED